Analysis of CD137 and CD137L Expression in Human Primary Tumor Tissues
Open Access
- 1 April 2008
- journal article
- Published by Croatian Medical Journals in Croatian Medical Journal
- Vol. 49 (2), 192-200
- https://doi.org/10.3325/cmj.2008.2.192
Abstract
To assess the expression of CD137 and CD137L in human primary tumor tissues and their potential role in tumor immunity.Expression of CD137 and CD137L was assessed by immunohistochemistry in frozen sections of 12 human normal tissues, 15 benign tumors ...Keywords
This publication has 21 references indexed in Scilit:
- Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survivalTransplant International, 2004
- 4-1BB-ligand is regulated on human dendritic cells and induces the production of IL-12Cellular Immunology, 2003
- Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responsesEuropean Journal of Immunology, 2002
- Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells.2002
- 4-1BB Ligand-Mediated Costimulation of Human T Cells Induces CD4 and CD8 T Cell Expansion, Cytokine Production, and the Development of Cytolytic Effector FunctionPublished by The American Association of Immunologists ,2002
- 4-1BB Ligand Induces Cell Division, Sustains Survival, and Enhances Effector Function of CD4 and CD8 T Cells with Similar EfficacyThe Journal of Immunology, 2001
- CD137 Expression in Tumor Vessel WallsAmerican Journal of Clinical Pathology, 2001
- Constitutive Expression of Functional 4-1BB (CD137) Ligand on Carcinoma CellsThe Journal of Immunology, 2000
- Biochemical and immunological characteristics of 4-1BB (CD137) receptor and ligand and potential applications in cancer therapy.1999
- ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineagesBlood, 1995